Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-12-004666
Filing Date
2012-03-08
Accepted
2012-03-08 20:23:11
Documents
1
Period of Report
2012-03-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3928
  Complete submission text file 0001179110-12-004666.txt   5059
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 157 TECHNOLOGY DRIVE IRVINE CA 92618
Business Address
Singh Amar (Reporting) CIK: 0001486809 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 12678745